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Obesity and Cardiac Metabolism in Women*
Heinrich Taegtmeyer, MD, DPHIL, FACC, Mohamed F. Algahim, BSC
Houston, TexasObesity is a vexing problem for the clinician and for
the cardiovascular physiologist alike. Although we
tend to blame an “obesogenic” environment, nobody
really knows the cause for the current obesity epi-
demic. Is it the environment? Is it genes? Or is it the
environment acting on certain genes? Currently ap-
proximately 6% of the American population is clini-
cally severely obese (1) and it is well documented that
obesity reduces life expectancy (2). Death and disabil-
ity from heart disease feature prominently in obesity.
Most importantly, the dysregulated lipid metabolism
in obesity does not stop in the arterial wall. Obesity is,
for example, an independent risk factor for heart
failure, as defined by criteria of the Framingham study
(3). The data also show that women are more likely to
develop heart failure than men (14% vs. 11%). It is
tempting to speculate that the gender difference can be
traced to the metabolism of energy-providing substrates.
See page 424
The study by Peterson et al. (4) in this issue of
iJACC ( JACC: Cardiovascular Imaging) suggests that
this might be the case. In a series of elegantly per-
formed tracer kinetic experiments, complemented by
extensive metabolic and hemodynamic profiling, the
investigators found that a pre-existing increase in
myocardial blood flow and oxygen consumption
(MVO2) in women was further amplified by obesity.
Furthermore, both myocardial blood flow and MVO2
were directly related to body mass index in women,
but not in men. In spite of greater cardiac work, the
heart’s efficiency (defined as cardiac work/MVO2) was
less in women than in men. Because energy can
neither be created nor destroyed, the results suggest
impaired coupling of fatty acid oxidation to adenosine
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(5) in the heart of obese women. The investigators
imply that uncoupling proteins are the mediators for
reduced cardiac efficiency. This is a reasonable specu-
lation; although, there is also a cardioprotective role
for uncoupling proteins that needs to be considered.
We have speculated that uncoupling proteins reduce
the formation of reactive oxygen species (5,6) and
lessen the consequences of oxidative stress on the heart.
Circulatory dysfunction in massively obese people
associated with cardiac enlargement (during life and at
autopsy) was first suggested in the “Munich beer heart” at
the beginning of the last century (7) and again in a study
on adiposity of the heart in the 1930s (8). It has long
been appreciated that obesity is associated with increases
in blood volume and cardiac output that are proportional
to body weight and duration of obesity (9). There are also
significant negative correlations between the ratio of
stroke work index to the left ventricular and diastolic
pressure and the amount of excess weight (10) as well as
left ventricular diastolic function and plasma free fatty
acid concentrations (11).
In the normal mammalian heart, free fatty acids
provide the bulk of energy providing substrates (12);
although, the heart exhibits a great amount of metabolic
flexibility (13). This flexibility seems to be compromised
when the heart is flooded with fatty acids and when the
heart becomes less responsive to insulin. Although the
mechanisms underlying impaired glucose uptake in the
presence of fatty acids are complex, the inhibition of
glucose oxidation by fatty acids at the level of the
pyruvate dehydrogenase complex is undisputed. Nature
seems to find ways to protect the heart muscle cell from
an oversupply of fuel in the form of carbohydrates and
also in the form of fatty acids. Although the mechanisms
for the inhibition of glucose metabolism are relatively
well understood, the heart’s response to excess fatty acids
is more complex. Although fatty acids contain more than
twice the amount of chemical energy (by weight) than
carbohydrates, the amount of usable adenosine triphos-
phate produced from oxidation of fatty acids is less than
the amount of adenosine triphosphate derived from
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435xidation of glucose (14). Also, the “uncoupling” effect of
atty acid oxidation is not an entirely new observation.
arlier studies, 1 of them in vitro (15) and the other ex
ivo (16), readily explain the increased MVO2 and
ecreased cardiac efficiency (4).
The questions remain: Are the increase in fatty acid
xidation and the decrease in cardiac efficiency cause or
onsequence for the presumed increased death and dis-
bility from heart failure in obese women? Is the increase
n cardiac mass in obese subjects the result of true
ypertrophy (synthesis of contractile proteins) or “meta-
olic hypertrophy” (increase in mitochondrial mass
nd/or endogenous substrates)? Figure 4 of the study by
eterson et al. (4) seems to suggest the latter. It would
lso be interesting to know how to reconcile the present
ndings with those of animal models of obesity that
uggest the opposite gender effects: predominance of
atty acid metabolism in hearts from male rather than
emale animals (17). Furthermore, the variability in body
omposition between the obese male and obese female is
ignificant in fat mass, percent fat, and fat-free mass, as
ell as a relatively larger waist circumference in women.
lthough these differences are consistent with the pat-
ern of change of obesity in women (a shift fromheart”—revisited. Beitr Pathol 1976;
157:1–13. fluences left ventrinto consideration when comparing obese and nonobese
omen as well as men, who have a more consistent
attern of visceral adiposity throughout life? Also, visceral
diposity in women is associated with decreased skeletal
uscle uptake of free fatty acids (18) and impaired left
entricular remodeling compared to that of men (19).
hese factors may contribute to the gender differences in
yocardial fatty acid oxidation and cardiac function.
astly, the readers would probably like to know whether
he observed changes are reversible with weight loss.
In short, there is still much to be learned about the
woman’s heart.” It is, however, exciting to see that the
ools of metabolic imaging are now sophisticated enough
o address these questions. After nearly 3 decades of
ssessing regional differences, metabolic imaging with
ositron-labeled tracers is now reaching deeper and
eeper into cardiac physiology and biochemistry.
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